Market Price

88.64 

-1.13 -1.3%

as of Aug 20 '19

52 Week Range:

73.16 117.79


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 4.02
5.24
6.52
7.68
9.27
10.68
12.21
14.51
16.26
18.30
21.24
growth rate 30.4% 24.4% 17.8% 20.7% 15.2% 14.3% 18.8% 12.1% 12.6% 16.1%
Earnings BIT 28.43
40.60
50.13
56.74
59.84
65.82
86.88
93.96
90.84
99.42
109.54
growth rate 42.8% 23.5% 13.2% 5.5% 10.0% 32.0% 8.2% -3.3% 9.5% 10.2%
Avg.PE 24.88
24.10
30.12
31.65
27.62
40.32
33.20
34.43
49.54
27.59
28.14
growth rate -3.1% 25.0% 5.1% -12.7% 46.0% -17.7% 3.7% 43.9% -44.3% 2.0%
ROA 12.33
15.65
15.98
15.50
13.69
13.02
8.53
6.85
6.12
9.42
8.08
growth rate 26.9% 2.1% -3.0% -11.7% -4.9% -34.5% -19.7% -10.7% 53.9% -14.2%
ROE 18.35
20.47
19.89
18.48
15.84
14.85
14.61
13.96
11.37
15.83
12.01
growth rate 11.6% -2.8% -7.1% -14.3% -6.3% -1.6% -4.5% -18.6% 39.2% -24.1%
ROIC 15.42
19.65
18.95
18.18
15.84
14.79
8.11
8.65
7.79
11.94
9.53
growth rate 27.4% -3.6% -4.1% -12.9% -6.6% -45.2% 6.7% -9.9% 53.3% -20.2%
Cur. Ratio 2.15
2.75
4.39
5.68
7.01
7.77
1.89
2.45
1.87
1.83
2.76
growth rate 27.9% 59.6% 29.4% 23.4% 10.8% -75.7% 29.6% -23.7% -2.1% 50.8%
Quick Ratio 1.31
2.24
3.70
4.83
6.18
6.94
1.28
1.79
1.21
1.21
1.87
growth rate 71.0% 65.2% 30.5% 28.0% 12.3% -81.6% 39.8% -32.4% 0.0% 54.6%
Leverage 1.34
1.28
1.22
1.17
1.14
1.14
2.20
1.90
1.82
1.56
1.42
growth rate -4.5% -4.7% -4.1% -2.6% 0.0% 93.0% -13.6% -4.2% -14.3% -9.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 30.30
29.10
32.10
34.99
42.59
40.28
71.98
60.49
83.25
91.23
99.55
growth rate -4.0% 10.3% 9.0% 21.7% -5.4% 78.7% -16.0% 37.6% 9.6% 9.1%
Acct.Payable 29.53
30.23
35.75
24.35
14.71
32.51
32.56
35.73
growth rate 2.4% 18.3% -31.9% -39.6% 121.1% 0.2% 9.7%
Cur.Assets 55.30
93.00
129.70
175.74
211.91
277.77
181.30
198.29
188.44
199.34
226.31
growth rate 68.2% 39.5% 35.5% 20.6% 31.1% -34.7% 9.4% -5.0% 5.8% 13.5%
Total Assets 154.50
187.80
228.60
271.72
312.55
376.87
861.53
879.69
948.63
963.64
981.36
growth rate 21.6% 21.7% 18.9% 15.0% 20.6% 128.6% 2.1% 7.8% 1.6% 1.8%
Cash 3.40
46.40
77.30
114.78
144.74
208.75
50.29
84.80
38.64
40.42
54.27
growth rate 1,264.7% 66.6% 48.5% 26.1% 44.2% -75.9% 68.6% -54.4% 4.6% 34.3%
Inventory 16.60
14.00
15.70
18.64
20.69
24.82
49.62
46.09
57.25
60.70
67.19
growth rate -15.7% 12.1% 18.7% 11.0% 20.0% 99.9% -7.1% 24.2% 6.0% 10.7%
Cur.Liabilities 25.70
33.80
29.50
30.91
30.23
35.75
95.52
81.12
101.01
108.40
82.06
growth rate 31.5% -12.7% 4.8% -2.2% 18.3% 167.2% -15.1% 24.5% 7.3% -24.3%
Liabilities 40.00
40.70
41.20
39.71
39.53
45.51
469.63
415.98
427.59
346.76
289.74
growth rate 1.8% 1.2% -3.6% -0.4% 15.1% 931.8% -11.4% 2.8% -18.9% -16.4%
LT Debt 6.70
0.00
3.40
0.02
3.40
3.90
297.50
260.96
245.49
183.96
156.00
growth rate -100.0% -99.3% 14,682.6% 14.7% 7,528.2% -12.3% -5.9% -25.1% -15.2%
Equity 114.50
147.10
187.50
232.01
273.01
331.36
391.90
463.71
521.03
616.88
691.62
growth rate 28.5% 27.5% 23.7% 17.7% 21.4% 18.3% 18.3% 12.4% 18.4% 12.1%
Common Shares 29.00
29.00
30.00
30.00
30.00
31.00
31.00
32.00
32.00
32.00
32.00
growth rate 0.0% 3.5% 0.0% 0.0% 3.3% 0.0% 3.2% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 0.00
0.00
-1.10
6.61
13.88
8.19
13.20
41.30
23.03
27.53
19.17
growth rate 100.0% 110.0% -41.0% 61.2% 212.9% -44.2% 19.5% -30.4%
Cash Dividends 2.00
2.00
3.10
4.31
11.70
0.00
7.86
9.25
10.72
12.07
13.43
growth rate 0.0% 55.0% 39.1% 171.5% -100.0% 17.8% 15.9% 12.6% 11.3%
Cash From OA 22.90
48.10
39.00
44.90
53.78
55.69
85.35
103.83
107.61
110.62
118.70
growth rate 110.0% -18.9% 15.1% 19.8% 3.6% 53.3% 21.7% 3.7% 2.8% 7.3%
FCF per Share 0.62
1.54
1.06
1.24
1.31
1.17
1.85
2.50
2.25
2.63
2.67
growth rate 148.4% -31.2% 17.0% 5.7% -10.7% 58.1% 35.1% -10.0% 16.9% 1.5%
Sale Purchase of Stock 4.34
0.21
7.16
9.11
12.61
7.19
9.73
growth rate -95.3% 3,374.3% 27.2% 38.4% -42.9% 35.3%
FCF 18.00
44.00
31.00
38.00
40.00
47.00
72.00
62.00
84.00
83.00
99.00
growth rate 144.4% -29.6% 22.6% 5.3% 17.5% 53.2% -13.9% 35.5% -1.2% 19.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 232.10
219.40
255.10
291.87
310.39
337.17
541.38
552.49
553.20
594.79
643.68
growth rate -5.5% 16.3% 14.4% 6.4% 8.6% 60.6% 2.1% 0.1% 7.5% 8.2%
Op.Income 29.30
40.70
49.80
38.77
40.01
44.87
86.88
93.96
90.84
99.42
109.54
growth rate 38.9% 22.4% -22.2% 3.2% 12.2% 93.6% 8.2% -3.3% 9.5% 10.2%
IBT 28.40
40.60
50.10
56.74
59.84
65.82
77.05
87.06
82.93
88.49
99.03
growth rate 43.0% 23.4% 13.3% 5.5% 10.0% 17.1% 13.0% -4.7% 6.7% 11.9%
Net Income 19.10
26.80
33.30
38.77
40.01
44.87
52.83
59.72
55.97
90.07
78.57
growth rate 40.3% 24.3% 16.4% 3.2% 12.2% 17.7% 13.1% -6.3% 60.9% -12.8%
EPS 0.67
0.93
1.12
1.28
1.32
1.45
1.69
1.89
1.75
2.79
2.42
growth rate 38.8% 20.4% 14.3% 3.1% 9.9% 16.6% 11.8% -7.4% 59.4% -13.3%
Gross Profit 52.60
67.00
78.00
86.00
89.54
97.42
148.91
168.10
180.86
189.01
204.25
growth rate 27.4% 16.4% 10.3% 4.1% 8.8% 52.9% 12.9% 7.6% 4.5% 8.1%
R&D 2.90
3.30
3.20
2.89
3.42
3.62
4.81
5.99
7.33
9.31
11.59
growth rate 13.8% -3.0% -9.7% 18.4% 5.8% 32.8% 24.5% 22.3% 27.0% 24.6%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 28.51
25.67
27.26
26.97
27.01
growth rate -10.0% 6.2% -1.1% 0.2%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 98.60
101.21
99.55
99.83
101.60
growth rate 2.7% -1.6% 0.3% 1.8%
Acct.Payable 31.96
34.83
35.73
27.91
31.05
growth rate 9.0% 2.6% -21.9% 11.3%
Cur.Assets 241.14
225.71
226.31
221.67
231.89
growth rate -6.4% 0.3% -2.1% 4.6%
Total Assets 989.47
986.08
981.36
971.89
1,098.32
growth rate -0.3% -0.5% -1.0% 13.0%
Cash 62.48
42.67
54.27
39.00
41.67
growth rate -31.7% 27.2% -28.1% 6.9%
Inventory 70.07
71.78
67.19
66.76
68.43
growth rate 2.4% -6.4% -0.6% 2.5%
Cur.Liabilities 60.63
65.95
82.06
63.81
62.09
growth rate 8.8% 24.4% -22.2% -2.7%
Liabilities 326.25
300.87
289.74
261.38
365.98
growth rate -7.8% -3.7% -9.8% 40.0%
LT Debt 210.75
178.00
156.00
140.00
230.28
growth rate -15.5% -12.4% -10.3% 64.5%
Equity 663.22
685.20
691.62
710.51
732.35
growth rate 3.3% 0.9% 2.7% 3.1%
Common Shares 2.15
2.15
2.15
2.16
2.16
growth rate 0.1% 0.1% 0.2% 0.1%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 3.97
5.55
5.92
8.49
6.20
growth rate 40.1% 6.6% 43.5% -27.0%
Cash Dividends 0.01
0.00
0.00
15.14
growth rate -42.9% 0.0% 378,275.0%
Cash From OA 21.22
32.49
39.51
22.48
26.33
growth rate 53.1% 21.6% -43.1% 17.1%
Sale Purchase of Stock 5.32
growth rate
FCF 17.25
26.94
33.60
14.00
20.13
growth rate 56.1% 24.7% -58.3% 43.8%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 163.69
155.04
163.54
157.03
161.55
growth rate -5.3% 5.5% -4.0% 2.9%
Op.Income 28.51
25.67
27.26
26.97
27.01
growth rate -10.0% 6.2% -1.1% 0.2%
IBT 25.06
23.53
25.26
24.79
24.88
growth rate -6.1% 7.4% -1.9% 0.4%
Net Income 19.68
19.21
20.33
18.78
19.83
growth rate -2.4% 5.8% -7.6% 5.6%
EPS
growth rate
Gross Profit 53.47
48.00
51.33
49.10
53.92
growth rate -10.2% 6.9% -4.3% 9.8%
R&D 3.23
2.54
3.25
2.90
2.85
growth rate -21.4% 28.1% -11.0% -1.5%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (82.64)

YOY Growth Grade:

C (65.86)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 42.46 36.63 34.71
EPS / Growth 17.4% 2.42 24.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.3% 19.2% 19.2%
Future PE 32.50 38.52 38.52
Future EPS 10.91 14.01 14.01
Value Price
MOS %
87.63
-1.1%
133.45
50.6%
133.45
50.6%
MOS Price 43.81 66.73 66.73
IRT 12.03 11.00 11.00

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.